Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study

PURPOSE: The objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice. METHODS: This observational, retrospective, multicentre, nationwide study was performed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrero, Francisco, Mallada-Frechin, Javier, Martínez-Ginés, María Luisa, Marzo, María Eugenia, Meca-Lallana, Virginia, Izquierdo, Guillermo, Ara, José Ramón, Oreja-Guevara, Celia, Meca-Lallana, José, Forero, Lucía, Sánchez-Vera, Irene, Moreno, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117743/
https://www.ncbi.nlm.nih.gov/pubmed/32240213
http://dx.doi.org/10.1371/journal.pone.0230846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117743/
https://www.ncbi.nlm.nih.gov/pubmed/32240213
http://dx.doi.org/10.1371/journal.pone.0230846

Ejemplares similares